We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The judge said HHS “lacks the statutory authority under the Social Security Act … to issue a rule that compels drug manufacturers to disclose list prices.” Read More
A federal court in Delaware has denied Baxalta’s request for a new trial in a suit brought by Bayer over patent infringement by Baxalta’s hemophilia A drug Adynovate. Read More